Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
News
News
Wuhan Desheng Biochemical Technology Co., Ltd
Home News

Chemiluminescence technology is widely used in clinical applications but difficult to develop

China Wuhan Desheng Biochemical Technology Co., Ltd certification
China Wuhan Desheng Biochemical Technology Co., Ltd certification
As a distributor of hospital agent , your Blood Collection Tube Additives is very suit for my needs , i think we have establish a good business with each other , thank you !

—— Tony

I'm Online Chat Now
Company News
Chemiluminescence technology is widely used in clinical applications but difficult to develop
Latest company news about Chemiluminescence technology is widely used in clinical applications but difficult to develop

Chemiluminescence technology is widely used in clinical practice. Chemiluminescence is a type of immunodiagnosis, which uses the specific reaction between antigen and antibody to determine the concentration of disease markers in the body to determine the body state of the human body. It is widely used in infectious diseases, heart diseases, tumors, pregnancy detection, etc. Compared with other immunodiagnostic methods, chemiluminescence has become the mainstream of immunodiagnosis due to its systematic advantages in safety, automated operation, test accuracy, and test speed. It surpasses other technologies in performance. 

 

latest company news about Chemiluminescence technology is widely used in clinical applications but difficult to develop  0

chemiluminescent-reagent

 

While chemiluminescence products have been widely used in clinical practice, they also encountered some difficult development problems, mainly in the following aspects. The biggest reason is the low concentration of markers and the difficulty of detection.

 

1. The fundamental reason is that the concentration of the test substance (antigen, antibody) in the sample is low, which requires more precision and standardization from R&D, production to use-the content of carbohydrates, fats, etc. in biochemical diagnostic tests are common in the human body It is the g/L-μg/L level, while the immunodiagnostic target antigens and antibodies are only at the μg/L-pg/L level, and the difference between the two is about 106 times.

 

2. The instrument and reagents are closed, and the development capabilities of the enterprise's instruments and reagents are very high. The instrument determines the lower limit, and the reagent determines the upper limit;

 

3. Cutting-edge technologies in various fields are required: mechanical automation, optics, materials, statistics, etc. There are obviously insufficient talents in the field, and it is difficult to train;

 

4. High R&D cost and long cycle.

Compared with the differences in different types of technologies, domestic manufacturers are more important to product development and quality control capabilities. As one of the leading manufacturers of chemiluminescence reagents, Desheng should have higher requirements for the quality of products. Desheng’s chemiluminescence reagent products mainly include acridinium esters, luminol and isoluminol, and rely on super high Cost-effective, professional scientific research and technical team, and strong after-sales service have been unanimously recognized by many customers.

Pub Time : 2020-08-21 09:00:00 >> News list
Contact Details
Wuhan Desheng Biochemical Technology Co., Ltd

Contact Person: Miss. Ankiwang

Tel: 8615071057538

Fax: 86-0711-3704589

Send your inquiry directly to us (0 / 3000)